SEMA4D and neoplasm: To identify the primary source of SEMA4D in the tumor microenvironment (TME), we conducted a single-cell RNA sequencing (scRNA-seq) transcriptome analysis of 15 independent datasets of 9 tumors with high SEMA4D expression.